1. White, N White N, Chalk J, Hu Y, Pins S, Joseph C, Antoniou P, Wimberger S, Svensson S, Caetano-Silva S, Mudde A, Rai R, Selvaraj S, Feist W, Romito M, Sienski G, Nitsch R, Booth C, Santilli G, Cavazza A, Porteus M, Maresca M, Thrasher A, Turchiano G . Unveiling the cut-and-repair cycle of designer nucleases in human stem and T cells via CLEAR-time dPCR.” Nature Communications vol. 16,1 9571. 3 Nov. 2025, doi:10.1038/s41467-025-65182-4
  2. Cavazza A*, Francisco J. Molina-Estévez, Álvaro Plaza Reyes, Victor Ronco, Asma Naseem, Špela Malenšek, Peter Pečan, Annalisa Santini, Paula Heredia, Araceli Aguilar-González, Houria Boulaiz, Qianqian Ni, Marina Cortijo-Gutierrez, Kristina Pavlovic, Inmaculada Herrera, Berta de la Cerda, Emilio M. Garcia-Tenorio, Eva Richard, Sergio Granados-Principal, Arístides López-Márquez, Mariana Köber, Marijana Stojanovic, Melita Vidaković, Irene Santos-Garcia, Lorea Blázquez, Emily Haughton, Dongnan Yan, Rosario María Sánchez-Martín, Loubna Mazini, Gloria Gonzalez Aseguinolaza, Annarita Miccio, Paula Rio, Lourdes R. Desviat, Manuel A.F.V. Gonçalves, Ling Peng, Cecilia Jiménez-Mallebrera, Francisco Martin Molina, Dhanu Gupta, Duško Lainšček, Yonglun Luo*, Karim Benabdellah*. Advanced Delivery Systems for Gene Editing: A Comprehensive Review from the GenE-HumDi COST Action Working group. Molecular Therapy – Nucleic Acids, 2025, 102457, ISSN 2162-2531
  3. Bahal S, Zinicola M, Moula SE, Whittaker TE, Schejtman A, Naseem A, Blanco E, Vetharoy W, Hu YT, Rai R, Gomez-Castaneda E, Cunha-Santos C, Burns SO, Morris EC, Booth C, Turchiano G, Cavazza A, Thrasher AJ, Santilli G. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia. J Allergy Clin Immunol. 2024 Jul;154(1):195-208.e8
  4. Rai R, Steinberg Z, Romito M, Zinghirino F, Hu YT, White N, Naseem A, Thrasher AJ, Turchiano G, Cavazza A*. CRISPR/Cas9-Based Disease Modeling and Functional Correction of Interleukin 7 Receptor Alpha Severe Combined Immunodeficiency in T-Lymphocytes and Hematopoietic Stem Cells. Hum Gene Ther. 2024 Apr;35(7-8):269-283
  5. Whittaker TE, Moula SE, Bahal S, Bakri FG, Hayajneh WA, Daoud AK, Naseem A, Cavazza A, Thrasher AJ, Santilli G. Multidimensional Response Surface Methodology for the Development of a Gene Editing Protocol for p67phox-Deficient Chronic Granulomatous Disease. Hum Gene Ther. 2024 Apr;35(7-8):298-312.
  6. Cavazza A*, Hendel A*, Bak RO*, Rio P, Guell M, Lainscek D, Arechevala-Gomeza V, Peng L,….Miccio A, Martin F, Turchiano G, Cathomen T, Luo Y*, Tsai SQ*, Benabdellah K*, COST Action CA21113. Progress and Harmonization of Gene Editing to Treat Human Diseases (Proceeding of COST Action CA21113 GenE-HumDi). Mol Ther Nucleic Acids. 2023 Oct 29;34:102066. doi: 10.1016/j.omtn.2023.102066.
  7. Rai R, Vetharoy W, Naseem A, Steinberg Z, Thrasher AJ, Santilli G, Cavazza A*. Optimized cell culture conditions promote ex-vivo manipulation and expansion of primitive hematopoietic stem cells for therapeutic gene editing. MOLECULAR THERAPY – METHODS AND CLINICAL DEVELOPMENT. Feb 28;29:58-69. doi: 10.1016/j.omtm.2023.02.014
  8. Rai, R., Romito, M., Rivers, E., Turchiano, G., Blattner, G., Vetharoy, W., …Cavazza, A*. (2020). Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott – Aldrich Syndrome. NATURE COMMUNICATIONS, 11 (1), doi:10.1038/s41467-020-17626-2

* Corresponding author